Del Carmen Jeffrey
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Del Carmen Jeffrey. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CPRX | Chief Commercial Officer | Tax Withholding | 3,839 | — | — | Dec 29, 2025 |
| CPRX | Chief Commercial Officer | Option Exercise | 8,039 | — | — | Dec 8, 2025 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,983 | $4.21 | $46,238 | Nov 26, 2025 |
| CPRX | Chief Commercial Officer | Option Exercise | 5,603 | — | — | Nov 21, 2025 |
| CPRX | Chief Commercial Officer | Sale | 30,423 | $22.89 | $696,382 | Mar 3, 2025 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,667 | — | — | Feb 14, 2025 |
| CPRX | Chief Commercial Officer | Option Exercise | 8,667 | — | — | Dec 27, 2024 |
| CPRX | Chief Commercial Officer | Tax Withholding | 2,355 | — | — | Dec 9, 2024 |
| CPRX | Chief Commercial Officer | Option Exercise | 30,000 | $2.86 | $85,800 | Aug 9, 2024 |
| CPRX | Chief Commercial Officer | Sale | 7,541 | $16.07 | $121,184 | Jun 7, 2024 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,667 | — | — | Feb 15, 2024 |
| CPRX | Chief Commercial Officer | Tax Withholding | 3,839 | — | — | Dec 27, 2023 |
| CPRX | Chief Commercial Officer | Tax Withholding | 3,942 | — | — | Jun 27, 2023 |
| CPRX | Chief Commercial Officer | Option Exercise | 20,983 | $2.24 | $47,002 | Mar 29, 2023 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,666 | — | — | Feb 15, 2023 |
| CPRX | Chief Commercial Officer | Option Exercise | 120,000 | $2.86 | $343,200 | Nov 11, 2022 |
| CPRX | Chief Commercial Officer | Sale | 14,140 | $14.05 | $198,667 | Aug 19, 2022 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,000 | — | — | Jun 28, 2022 |
| CPRX | Chief Commercial Officer | Option Exercise | 10,000 | — | — | Jun 24, 2021 |